A method for treating a neurodegenerative disease or cerebral ischemia arising from conditions selected from the group consisting of Status epilepticus, hypoglycaemia, hypoxia, anoxia, brain trauma, brain oedema, amyotropic lateral sclerosis, Huntington's disease, Alzheimer's disease, hypotonia, cardiac infarction, brain pressure (elevated intracranial pressure), ischaemic and haemorrhagic stroke, global cerebral ischaemia with heart stoppage, diabetic polyneuropathy, tinnitus, perinatal asphyxia, psychosis, schizophrenia, depression, and Parkinson's disease, the method of treatment comprising administering to a host in need of such treatment a therapeutic amount of a compound of formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 are as defined herein, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions containing a compound of formula (I).

Um método para tratar uma doença neurodegenerative ou um ischemia cerebral que levantam-se das circunstâncias selecionadas do epilepticus consistindo do status do grupo, a hipoglicemia, o hypoxia, o anoxia, o trauma do cérebro, o oedema do cérebro, o sclerosis lateral amyotropic, a doença de Huntington, a doença de Alzheimer, a hipotonia, o infarction cardiac, a pressão do cérebro (pressão intracranial elevated), o curso isquêmico e haemorrhagic, o ischaemia cerebral global com a parada do coração, o polyneuropathy diabetic, o tinnitus, o asphyxia perinatal, o psychosis, a esquizofrenia, o depression, e a doença de Parkinson, o método de tratamento que compreende que administra a um anfitrião na necessidade de tal tratamento um uma quantidade therapeutic de um composto do ## do ## STR1 da fórmula (I) wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, e R.sup.7 são como definidos nisto, ou um sal pharmaceutically aceitável disso, e as composições pharmaceutical que contêm um composto da fórmula (i).

 
Web www.patentalert.com

< (none)

< Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

> Thienopyrimidine and thienopyridine derivatives useful as anticancer agents

> (none)

~ 00053